CDNA
Closed
Caredx Inc
18.85
-0.69 (-3.53%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 19.54
Day's Range: 18.72 - 19.76
Send
sign up or login to leave a comment!
When Written:
9.14
Caredx Inc is a molecular diagnostics company that specializes in the development, marketing, and sale of diagnostic solutions for transplant patients. The company's products and services are designed to improve the clinical management of transplant patients by providing accurate and actionable information to healthcare providers. Caredx's primary focus is on developing non-invasive tests that can help identify rejection and other complications in transplant patients. The company's flagship product is the AlloSure® test, which is a non-invasive blood test that can detect organ rejection in kidney transplant patients. Caredx is headquartered in Brisbane, California, and has operations in the United States, Europe, and Australia. The company was founded in 1998 and went public in 2014.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








